These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 13958397

  • 1. Inhibition of some microsomal drug-metabolizing enzymes by inhibitors of cholesterol biosynthesis.
    KATO R, VASSANELLI P, CHIESARA E.
    Biochem Pharmacol; 1963 Apr; 12():349-51. PubMed ID: 13958397
    [No Abstract] [Full Text] [Related]

  • 2. FURTHER STUDIES ON THE INHIBITION AND STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYMES OF RAT LIVER BY VARIOUS COMPOUNDS.
    KATO R, CHIESARA E, VASSANELLI P.
    Biochem Pharmacol; 1964 Jan; 13():69-83. PubMed ID: 14106733
    [No Abstract] [Full Text] [Related]

  • 3. VARIATION IN THE ACTIVITY OF LIVER MICROSOMAL DRUG-METABOLIZING ENZYMES IN RATS IN RELATION TO THE AGE.
    KATO R, VASSANELLI P, FRONTINO G, CHIESARA E.
    Biochem Pharmacol; 1964 Jul; 13():1037-51. PubMed ID: 14201126
    [No Abstract] [Full Text] [Related]

  • 4. [VARIATIONS IN THE ENZYME ACTIVITY AND PHARMACOLOGIC EFFECTS IN RELATION TO AGE].
    TRABUCCHI E, CHIESARA E.
    G Gerontol Suppl; 1964 Jul; 23():SUPPL 32:71-99. PubMed ID: 14185934
    [No Abstract] [Full Text] [Related]

  • 5. Fixed drug eruption to carisoprodol and cross reaction with meprobamate.
    HONEYCUTT WM, CURTIS AC.
    JAMA; 1962 May 26; 180():691-2. PubMed ID: 13908692
    [No Abstract] [Full Text] [Related]

  • 6. Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.
    Kumar M, Dillon GH.
    Eur J Pharmacol; 2016 Mar 15; 775():149-58. PubMed ID: 26872987
    [Abstract] [Full Text] [Related]

  • 7. METABOLIC FACTORS DETERMINING A HIGHER RESISTANCE TO STRYCHNINE IN GUINEA PIGS.
    KATO R, VASSANELLI P, FRONTINO G.
    Arch Int Pharmacodyn Ther; 1963 Aug 02; 144():416-22. PubMed ID: 14060864
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of pentobarbital and meprobamate metabolism by some 'inducers' of drug-metabolizing enzymes.
    KATO R, VASSANELLI P, CHIESARA E.
    Experientia; 1962 Oct 15; 18():453-4. PubMed ID: 13958402
    [No Abstract] [Full Text] [Related]

  • 9. NEWER DRUGS IN THE TREATMENT OF HEADACHE.
    FRIEDMAN AP.
    Med Clin North Am; 1964 Mar 15; 48():445-57. PubMed ID: 14149244
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic modeling of carisoprodol and meprobamate disposition in adults.
    Lewandowski TA.
    Hum Exp Toxicol; 2017 Aug 15; 36(8):846-853. PubMed ID: 27758843
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of drug metabolism in the mouse by a hypocholesterolemic agent, AY-9944.
    Marton AV, Chappel CI.
    Experientia; 1964 Sep 15; 20(9):517-8. PubMed ID: 5856346
    [No Abstract] [Full Text] [Related]

  • 12. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH, Johnson-Davis KL.
    Methods Mol Biol; 2016 Sep 15; 1383():105-14. PubMed ID: 26660179
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patients.
    Tse SA, Atayee RS, Best BM, Pesce AJ.
    J Anal Toxicol; 2012 May 15; 36(4):221-31. PubMed ID: 22511696
    [Abstract] [Full Text] [Related]

  • 15. Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate.
    Carbonaro TM, Nguyen V, Forster MJ, Gatch MB, Prokai L.
    Neuropharmacology; 2020 Sep 01; 174():108152. PubMed ID: 32479814
    [Abstract] [Full Text] [Related]

  • 16. Impairment due to intake of carisoprodol.
    Bramness JG, Skurtveit S, Mørland J.
    Drug Alcohol Depend; 2004 Jun 11; 74(3):311-8. PubMed ID: 15194209
    [Abstract] [Full Text] [Related]

  • 17. Transfer of carisoprodol to breast milk.
    Nordeng H, Zahlsen K, Spigset O.
    Ther Drug Monit; 2001 Jun 11; 23(3):298-300. PubMed ID: 11360042
    [Abstract] [Full Text] [Related]

  • 18. Quantitative analysis of carisoprodol and meprobamate in whole blood using benzylcarbamate and deuterated meprobamate as internal standards.
    Downey D, Simons K, Ota K, Kerrigan S.
    J Anal Toxicol; 2009 Jun 11; 33(5):278-82. PubMed ID: 19671248
    [Abstract] [Full Text] [Related]

  • 19. Induction of hepatic carisoprodol-metabolizing enzyme by pretreatment with some neuropsychotropic drugs in rats.
    KATO R, CHIESARA E, FRONTINO G.
    Jpn J Pharmacol; 1961 Sep 11; 11():31-6. PubMed ID: 14454281
    [No Abstract] [Full Text] [Related]

  • 20. Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine.
    Wang G, Huynh K, Barhate R, Rodrigues W, Moore C, Coulter C, Vincent M, Soares J.
    J Anal Toxicol; 2011 Mar 11; 35(2):108-12. PubMed ID: 21396230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.